Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. VIROCLINICS-DDL is the global leader in clinical trial management services, focused on viral targets such as influenza, COVID-19, RSV, HBV and Polio. REPROCELL will provide sample processing services in Japan to VIROCLINICS-DDL and will support [...]

BRANFORD, Conn. -- IsoPlexis, the leader in single-cell functional proteomics, today announced a partnership with the Division of Infectious Diseases, Department of Medicine at Columbia University, IsoPlexis' Single-Cell Secretome immune profiling solutions will be used to study cellular drivers of durable and protective immune response to COVID-19. (PRNewsfoto/IsoPlexis) T cell and other immune cell polyfunctional cytokine responses on IsoPlexis' platform have previously [...]

CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer [...]

CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer [...]

TUCSON, Ariz.  -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder). On August 13, 2020, BioSpyder filed a lawsuit seeking a declaration that it does not infringe HTG’s U.S. Patent No. 8,741,564 (the ’564 patent). In [...]

A consortium of public and private organizations, of which Serstech is part, has been granted funding from the European Commission. The project aims to develop technologies, based on Raman and SERS (Surface Enhanced Raman Spectroscopy), to detect and identify chemical warfare agents and toxic industrial compounds in liquid and gas form. Serstech will supply modified [...]

We are so pleased to announce the addition to our current building - a state-of-the-art, 12,000 sq.ft. space designated for Research & Development, among other departments. This addition brings CANNON Instrument Company's facility to a whopping 50,000 sq.ft. We are growing and advancing, with so many exciting products and events ahead, and this is a [...]

Capital raised will scale the Tapestri Platform to advance the development of precision medicine through improved biomarker discovery and drug development SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced $70 million in its Series C financing led by Novo Growth, the growth equity arm of [...]

OLUMBUS, Ohio and BOSTON -- METTLER TOLEDO International Inc. (NYSE: MTD) and TetraScience, Inc. announce a new collaboration to knock down life sciences R&D data silos by providing complete and unified R&D data in the cloud. The integration will join METTLER TOLEDO's precision instruments, such as balances, pH meters, titrators, UV/VIS spectrophotometers, density, refractometers, and LabX™ laboratory software with the TetraScience Platform [...]

• Tender offer acceptance of 47% did not reach minimum threshold of 66.67% • QIAGEN Supervisory Board and Managing Board respect the views of shareholders • Focus on execution with strong outlook for 2020 and 2021, QIAGEN to continue strategy of creating value through Sample to Insight portfolio for growing molecular testing needs • QIAGEN [...]